Direct and Indirect Anticancer Activity of Plant-Derived Alkaloid Conophylline

Area of Science:

• Oncology
• Pharmacology
• Natural Products Chemistry

Background:

• K-Ras is a key oncogene driving human cancer development.
• K-Ras transformation alters fibroblast morphology and promotes tumor growth.
• Cancer-associated fibroblasts contribute to tumor progression.

Purpose of the Study:

• To identify compounds that reverse K-Ras-induced cellular changes.
• To evaluate the anticancer potential of the isolated alkaloid, conophylline.
• To investigate conophylline's effects on cancer-associated fibroblasts and tumor growth.

Main Methods:

• Screening microbial and plant extracts for compounds inducing flat morphology in K-Ras-transformed cells.
• Isolation and identification of conophylline from Ervatamia microphylla.
• Assessing conophylline's effects on K-Ras-NRK cell morphology, invasion, and tumor growth in mice.
• Evaluating conophylline's impact on inflammatory cytokine secretion by pancreatic cancer-associated fibroblasts.
• Testing the efficacy of conophylline in combination with gemcitabine.

Main Results:

• Conophylline was isolated from Ervatamia microphylla and induced flat morphology in K-Ras-transformed cells.
• Conophylline inhibited cellular invasion and K-Ras-NRK tumor growth in vivo.
• Conophylline suppressed inflammatory cytokine secretion by pancreatic cancer-associated fibroblasts.
• Conophylline demonstrated oral activity and enhanced gemcitabine's efficacy against pancreatic cancer in mice.

Conclusions:

• Conophylline, a plant-derived alkaloid, exhibits direct and indirect anticancer activities.
• Conophylline normalizes K-Ras-transformed cell phenotype and inhibits tumor progression.
• Conophylline shows significant promise as a novel, orally active anticancer therapeutic agent.